Literature DB >> 16938575

Dicentric (7;9)(p11;p11) is a rare but recurrent abnormality in acute lymphoblastic leukemia: a study of 7 cases.

Jinlan Pan1, Yongquan Xue, Yafang Wu, Yong Wang, Juan Shen.   

Abstract

A clinical and experimental study of acute lymphoblastic leukemia (ALL) with a dic(7;9)(p11;p11) included 7 patients (5 males and 2 females) with a median age of 32 years. Cytogenetic analysis of bone marrow cells using an R-band technique showed a solitary dic(7;9) in 2 cases and a dic(7;9) accompanied by other abnormalities in 5 cases, of which 4 had also a t(9;22)(q34;q11). A minor breakpoint region (m-bcr) BCR/ABL rearrangement, corresponding to the fusion product gene p190, was detected by interphase FISH in 3 of these cases, Immunophenotyping analysis classified five of the 6 cases as B-lineage ALL. In 6 cases, FISH using whole chromosome painting (WCP) probes for chromosome 7 and 9 confirmed the reciprocal translocation between chromosomes 7 and 9; centromeric probes for chromosomes 7 and 9 confirmed the dicentric nature of the abnormal chromosome. The outcome of these ALL cases with simultaneous dic(7;9) and t(9;22) was worse than that of cases with an isolated dic(7;9). Our study brings the total number of published ALL cases with a dic(7;9) to 18. We consider the dic(7;9) a rare but recurrent abnormality, which may represent a distinct cytogenetic subgroup in B-ALL.

Entities:  

Mesh:

Year:  2006        PMID: 16938575     DOI: 10.1016/j.cancergencyto.2006.03.016

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  2 in total

1.  Heterogeneous breakpoints in patients with acute lymphoblastic leukemia and the dic(9;20)(p11-13;q11) show recurrent involvement of genes at 20q11.21.

Authors:  Qian An; Sarah L Wright; Anthony V Moorman; Helen Parker; Mike Griffiths; Fiona M Ross; Teresa Davies; Christine J Harrison; Jon C Strefford
Journal:  Haematologica       Date:  2009-07-07       Impact factor: 9.941

2.  Dicentric (7;12)(p11;p11) in T/Myeloid Mixed-Phenotype Acute Leukemia

Authors:  Smeeta Gajendra; Akshay Ramesh Gore; Nitin Sood; Manorama Bhargav
Journal:  Turk J Haematol       Date:  2021-06-30       Impact factor: 1.831

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.